June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Transient receptor potential vanilloid 1-deficiency protects from immune-mediated corneal nerve damage in dry eye
Author Affiliations & Notes
  • Manuela Pizzano
    Innate Immunity Laboratory, CONICET-Academia Nacional de Medicina Instituto de Medicina Experimental, Buenos Aires, Buenos Aires, Argentina
  • Alexia Vereertbrugghen
    Innate Immunity Laboratory, CONICET-Academia Nacional de Medicina Instituto de Medicina Experimental, Buenos Aires, Buenos Aires, Argentina
  • Florencia Sabbione
    Innate Immunity Laboratory, CONICET-Academia Nacional de Medicina Instituto de Medicina Experimental, Buenos Aires, Buenos Aires, Argentina
  • Irene Angelica Keitelman
    Innate Immunity Laboratory, CONICET-Academia Nacional de Medicina Instituto de Medicina Experimental, Buenos Aires, Buenos Aires, Argentina
  • Carolina Maiumi Shiromizu
    Innate Immunity Laboratory, CONICET-Academia Nacional de Medicina Instituto de Medicina Experimental, Buenos Aires, Buenos Aires, Argentina
  • Douglas Vera
    Innate Immunity Laboratory, CONICET-Academia Nacional de Medicina Instituto de Medicina Experimental, Buenos Aires, Buenos Aires, Argentina
  • Federico Fuentes
    Confocal Microscopy, CONICET-Academia Nacional de Medicina Instituto de Medicina Experimental, Buenos Aires, Buenos Aires, Argentina
  • Mirta Nilda Giordano
    Innate Immunity Laboratory, CONICET-Academia Nacional de Medicina Instituto de Medicina Experimental, Buenos Aires, Buenos Aires, Argentina
  • Analía Trevani
    Innate Immunity Laboratory, CONICET-Academia Nacional de Medicina Instituto de Medicina Experimental, Buenos Aires, Buenos Aires, Argentina
  • Jeremias Gaston Galletti
    Innate Immunity Laboratory, CONICET-Academia Nacional de Medicina Instituto de Medicina Experimental, Buenos Aires, Buenos Aires, Argentina
  • Footnotes
    Commercial Relationships   Manuela Pizzano None; Alexia Vereertbrugghen None; Florencia Sabbione None; Irene Keitelman None; Carolina Shiromizu None; Douglas Vera None; Federico Fuentes None; Mirta Giordano None; Analía Trevani None; Jeremias Galletti None
  • Footnotes
    Support  Wellcome Trust (221859/Z/20/Z), ANPCyT (PICT 2018-02911, PICT 2020-00138)
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 720. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Manuela Pizzano, Alexia Vereertbrugghen, Florencia Sabbione, Irene Angelica Keitelman, Carolina Maiumi Shiromizu, Douglas Vera, Federico Fuentes, Mirta Nilda Giordano, Analía Trevani, Jeremias Gaston Galletti; Transient receptor potential vanilloid 1-deficiency protects from immune-mediated corneal nerve damage in dry eye. Invest. Ophthalmol. Vis. Sci. 2023;64(8):720.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Transient receptor potential vanilloid 1 (TRPV1) channels are known to be involved in neurogenic inflammation and neurodegeneration in non-ocular tissues. TRPV1 channels are activated by inflammatory stimuli and we have reported increased TRPV1 signaling in dry eye. Here we hypothesized that TRPV1 channels could play a role in dry eye-associated corneal nerve damage.

Methods : Dry eye was induced for 10 days in 6-8-week-old C57BL/6 (wt) and TRPV1KO mice of both sexes by bilateral excision of the extraocular lacrimal glands. Conventional dry eye parameters were assessed along with corneal nerve function (mechanical sensitivity) and morphology (βIII tubulin staining). Also, CD4+ T cells from both strains were adoptively transferred to RAG1KO recipient mice and pharmacological inhibition of TRPV1 signaling was tested in wt mice (ocular SB-366791 instillation).

Results : Wt and TRPV1KO mice with dry eye had comparable tear deficiency (17±7 vs 23±18%, p=0.4), corneal epithelial damage (mean fluorescence 11.8±0.8 vs 11.1±0.6, p=0.6) and conjunctival CD4+ T cell infiltration (7.8±1.4% vs 3.1±0.1%, p>0.05). Also, there was no difference in interferon gamma- (2.85±3.62 vs 1.73±2.2, p=0.4) and interleukin 17-producing (2.4±4.6 vs 1.9±5.1, p=0.9) CD4+ T cells in the draining lymph nodes. Regarding the corneal nerves, TRPV1KO mice had significantly higher corneal mechanical sensitivity than wt mice at baseline (4.6±0.09 vs 3.75±0.1 cm, p<0.05). Intriguingly, corneal sensitivity in TRPV1KO mice was not affected by dry eye (-4%, p=0.3), which contrasted the observed drop in wt mice (-21%, p<0.01). In line with this finding, there was a trend for less dry eye-induced change in corneal nerve morphology in TRPV1KO than in wt mice (-4±9% vs -11±9%, p>0.05). Finally, adoptive transfer of CD4+ T cells from wt and TRPV1KO mice with dry eye to mice with normal TRPV1 expression and no dry eye led to comparable loss in corneal mechanical sensitivity in both groups. TRPV1 inhibition reduced dry eye-associated corneal sensitivity loss in wt mice.

Conclusions : These findings suggest that dry eye-induced corneal neuropathy depends on TRPV1 signaling and that it is independent from corneal epitheliopathy because TRPV1KO mice did not differ in any of the non-neural aspects of the disease. Moreover, TRPV1 signaling in corneal epithelium/nerves seems to be more relevant than in pathogenic CD4+ T cells.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×